Xiaotong He

496 total citations
16 papers, 333 citations indexed

About

Xiaotong He is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Xiaotong He has authored 16 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Xiaotong He's work include Cervical Cancer and HPV Research (4 papers), Glycosylation and Glycoproteins Research (2 papers) and T-cell and Retrovirus Studies (2 papers). Xiaotong He is often cited by papers focused on Cervical Cancer and HPV Research (4 papers), Glycosylation and Glycoproteins Research (2 papers) and T-cell and Retrovirus Studies (2 papers). Xiaotong He collaborates with scholars based in United Kingdom, Kenya and China. Xiaotong He's co-authors include Ian Hampson, Lynne Hampson, Anthony W. Oliver, Adam J. Donne, Shant Kumar, John Gaffney, John Davies, Mark Slevin, Gordon C. Jayson and Paul Brenchley and has published in prestigious journals such as PLoS ONE, Cancer Research and British Journal of Cancer.

In The Last Decade

Xiaotong He

15 papers receiving 328 citations

Peers

Xiaotong He
Brian Lane United Kingdom
David W. Gludish United States
Rajeev K. Boregowda United States
Nicoline Y. den Breems United Kingdom
Grant Jolly United States
Joshua J. Thompson United States
Brian Lane United Kingdom
Xiaotong He
Citations per year, relative to Xiaotong He Xiaotong He (= 1×) peers Brian Lane

Countries citing papers authored by Xiaotong He

Since Specialization
Citations

This map shows the geographic impact of Xiaotong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaotong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaotong He more than expected).

Fields of papers citing papers by Xiaotong He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaotong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaotong He. The network helps show where Xiaotong He may publish in the future.

Co-authorship network of co-authors of Xiaotong He

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaotong He. A scholar is included among the top collaborators of Xiaotong He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaotong He. Xiaotong He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
He, Xiaotong, et al.. (2024). Neoadjuvant chemotherapy vs upfront surgery for resectable locally advanced oral squamous cell carcinoma: A retrospective single center study. Advances in Clinical and Experimental Medicine. 34(8). 1307–1319. 1 indexed citations
3.
Megremis, Spyridon, Xiaotong He, James D.B. O’Sullivan, et al.. (2021). Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis. Communications Biology. 4(1). 419–419. 13 indexed citations
5.
Hampson, Lynne, Anthony W. Oliver, Xiaotong He, et al.. (2016). A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease. PLoS ONE. 11(1). e0147917–e0147917. 32 indexed citations
7.
He, Xiaotong, Bipasha Chakrabarty, Anthony W. Oliver, et al.. (2015). High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: Different implications for vaccine prevention and prognosis. European Journal of Cancer. 51(6). 776–785. 69 indexed citations
8.
Alosaimi, Bandar, et al.. (2013). Increased prevalence of JC polyomavirus in cervical carcinomas from women infected with HIV. Journal of Medical Virology. 86(4). 672–677. 13 indexed citations
9.
He, Xiaotong, et al.. (2012). No Biological Evidence of XMRV Infection in Cervical Smears from HIV/ HPV Positive and Negative Kenyan Women. PLoS ONE. 7(10). e47208–e47208. 3 indexed citations
10.
Oliver, Antony W., et al.. (2010). The HPV16 E6 binding protein Tip-1 interacts with ARHGEF16, which activates Cdc42. British Journal of Cancer. 104(2). 324–331. 35 indexed citations
11.
Donne, Adam J., Lynne Hampson, Xiaotong He, et al.. (2009). Cidofovir induces an increase in levels of low‐risk and high‐risk HPV E6. Head & Neck. 31(7). 893–901. 14 indexed citations
12.
Hampson, Lynne, Xiaotong He, Antony W. Oliver, et al.. (2009). Analogues of Y27632 increase gap junction communication and suppress the formation of transformed NIH3T3 colonies. British Journal of Cancer. 101(5). 829–839. 10 indexed citations
13.
Donne, Adam J., Lynne Hampson, Xiaotong He, et al.. (2009). Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease. Antiviral Therapy. 14(7). 939–952. 21 indexed citations
14.
He, Xiaotong, Paul Brenchley, Gordon C. Jayson, et al.. (2004). Hypoxia Increases Heparanase-Dependent Tumor Cell Invasion, Which Can Be Inhibited by Antiheparanase Antibodies. Cancer Research. 64(11). 3928–3933. 56 indexed citations
15.
He, Xiaotong, et al.. (2002). GPI-specific phospholipase D mRNA expression in tumor cells of different malignancy. Clinical & Experimental Metastasis. 19(4). 291–299. 19 indexed citations
16.
Slevin, Mark, Shant Kumar, Xiaotong He, & John Gaffney. (1999). Physiological concentrations of gangliosides gm1, gm2 and gm3 differentially modify basic-fibroblast-growth-factor-induced mitogenesis and the associated signalling pathway in endothelial cells. International Journal of Cancer. 82(3). 412–423. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026